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Prostate neoplasmsAbstract Background: Morus nigra L. belongs to the family Moraceae and is frequently used in
traditional medicine. Numerous studies have investigated the antiproliferative effects of various
extracts of different Morus species, but studies involving the in vitro cytotoxic effect of M. nigra
extract are very limited. The purpose of this study was to evaluate the phenolic composition and
antioxidant activity of dimethyl sulfoxide extract ofM. nigra (DEM) and to investigate, for the ﬁrst
time, the probable cytotoxic effect in human prostate adenocarcinoma (PC-3) cells together with the
mechanism involved. Methods: Total polyphenolic contents (TPC), ferric reducing antioxidant
power (FRAP) and phenolic compounds of DEM were evaluated using spectrophotometric proce-
dures and HPLC. The cytotoxic effect of DEM on PC-3 cells was revealed using the MTT assay.
Mechanisms involved in the cytotoxic effect of DEM on PC-3 cells were then investigated in terms
of apoptosis, mitochondrial membrane potential and cell cycle using ﬂow cytometry, while caspase
activity was investigated using luminometric analysis. Results: TPC and FRAP values were 20.7
± 0.3 mg gallic acid equivalents and 48.8 ± 1.6 mg trolox equivalents per g sample, respectively.
Ascorbic acid and chlorogenic acid were the major phenolic compounds detected at HPLC analysis.
DEM arrested the cell cycle of PC-3 cells at the G1 phase, induced apoptosis via increased caspaseaceutical
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Journal (2016), http://dx.doi.org/10.1016/j.jsactivity and reduced mitochondrial membrane potential. Conclusions: Our results indicate that
M. nigra may be a novel candidate for the development of new natural product based therapeutic
agents against prostate cancer.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The genus Morus, commonly known as mulberries, contains
10–16 species and belongs to the familyMoraceae.Morus alba
L., Morus rubra L. and Morus nigra L. are the most extensive
Morus species.M. nigra is native to western Asia and has been
cultivated in Europe since Pre-Roman times (Ozgen et al.,
2009; Kostic et al., 2013). The deep-colored Morus fruits are
a rich source of phenolic compounds, including ﬂavonoids,
anthocyanins and carotenoids (Kostic et al., 2013). Due to
their rich anthocyanin contents, the fruits of M. nigra in par-
ticular exhibit higher antioxidant activity than the otherMorus
species (Ozgen et al., 2009; Kostic et al., 2013). Recent studies
have reported antimicrobial, antioxidant, antidiabetic, anti-
HIV, anti-inﬂammatory, hypolipidemic, hepatoprotective,
anticancer, antiobesity, and neuroprotective activities of differ-
ent species of Morus and have attributed to those compounds
(Sakagami et al., 2007; Khalid et al., 2011; Kostic et al., 2013;
Ramesh et al., 2014; Grajek et al., 2015). M. nigra is used to
treat urinary incontinence, dizziness, sore throat, depression,
fever and cancer in traditional medicine (Khalid et al., 2011;
Kostic et al., 2013).
Prostate cancer is the ﬁfth most common cancer overall, the
second most prevalent malignancy worldwide and the second
greatest cause of cancer-related deaths among men after lung
cancer (Shahneh et al., 2014; Huo et al., 2015; Kim et al.,
2015). A combination of treatment options (radiation therapy,
brachytherapy, cryosurgery, chemotherapy, hormonal ther-
apy, and surgery) is often recommended for managing prostate
cancer. Of the conventional modalities for prostate cancer
treatment, chemotherapeutic drugs lead to various side effects.
Natural anticancer drugs derived from medicinal plants that
selectively induce apoptosis and/or growth arrest in cancer
cells without causing detrimental effect in healthy cells are
today available, and these natural products can serve as
chemotherapeutic agents (Shahneh et al., 2014).
Numerous studies have investigated the antiproliferative
effects of various extracts of different Morus species. Eo
et al. reported that 80% methanol extract of root bark of M.
alba L. exhibited a dose-dependent anticancer effect on human
colorectal carcinoma cell line (SW480) via induced cell growth
arrest and apoptosis (Eo et al., 2014). Fathy et al. demon-
strated that M. alba extract had a cytotoxic effect on hepato-
cellular cell line (Fathy et al., 2013). However, studies
involving the in vitro cytotoxic effect of M. nigra extract are
very limited. Qadir et al. demonstrated that M. nigra leaf
extract exhibited cytotoxic effect on human cervical cancer
(HeLa) cell line (Qadir et al., 2014). However, to the best of
our knowledge no previous study has investigated the cyto-
toxic effect of M. nigra extract on prostate cancer cells. The
purpose of this study was to therefore to evaluate the phenolic
composition and antioxidant properties of dimethyl sulfoxide
extract of M. nigra to investigate, for the ﬁrst time, the prob-t al., Antiproliferative and apoptotic eﬀe
ps.2016.06.002able cytotoxic effect in human prostate adenocarcinoma cells
together with the mechanism involved.
2. Materials and methods
2.1. Chemicals and reagents
All phenolic standards, methanol, folin phenol reagent,
sodium carbonate, potassium ferricyanide, trichloroacetic
acid, iron (III) chloride, gallic acid, trolox, acetonitrile, cis-
platin, phosphate buffer saline (PBS) tablet, trypan blue solu-
tion, dimethyl sulfoxide (DMSO), and thiazolyl blue
tetrazolium bromide (MTT dye) were purchased from Sigma
(St. Louis, MO, USA). Kaighn’s modiﬁcation of Ham’s F-12
(F-12K) and Eagle’s minimal essential medium (EMEM)
media were obtained from Lonza (Verviers, Belgium). Fetal
bovine serum (FBS) was obtained from Biochrom (Berlin,
Germany). Penicillin-streptomycin was purchased from Gibco
(Paisley, England) and trypsin-EDTA solution from Biological
Industries (Kibbutz Beit Haemek, Israel). All ﬂow cytometry
kits were obtained from BD Biosciences (San Diego, CA,
USA).
2.2. Drug preparation and treatment
Cisplatin was used as a reference anticancer agent for cytotox-
icity experiments due to its use in prostate cancer treatment
(Dhar et al., 2011). It was dissolved in absolute DMSO to pre-
pare a 1000 lg/mL stock solution.
External working concentrations of both extract and cis-
platin were prepared by further dilution with DMSO. The ﬁnal
concentration of DMSO did not exceed 0.5% in culture media
during any experiment, and this concentration did not affect
cell morphology or viability.
2.3. Plant collection and extraction
Fully mature fruits of M. nigra were harvested from Kelkit
town, Gumushane, Turkey. Samples were preserved in cool
bags for transportation to the laboratory. The fruits were
air-dried at room temperature for 20 days and converted into
a ﬁne powder using a blender and milling. The fruit powder
(1 g) was extracted with 20 mL DMSO in a mechanical shaker
(Shell Lab, Cornelius, OR, USA) in the dark for 24 h at 45 C.
The prepared 50 mg/mL stock DMSO extract of M. nigra
(DEM) was ﬁltered with Whatman No. 1 ﬁlter paper and a
0.2 lm ﬁlter and then stored at 20 C until used in further
experiments.
2.3.1. Estimation of total phenolic content (TPC)
Content of total phenolics of DEM was established by the
spectrophotometric method (Slinkard and Singleton, 1977)ct of Morus nigra extract on human prostate cancer cells. Saudi Pharmaceutical
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12.5 lL M. nigra extract was mixed with 62.5 lL freshly pre-
pared Folin–Ciocalteu reagent and 125 lL 20% sodium car-
bonate. This was incubated at room temperature for 30 min,
after which absorbance was measured at 760 nm. The results
were calculated using a standard gallic acid chart and were
expressed as milligrams of gallic acid equivalent per g sample.
2.3.2. Estimation of reducing power (FRAP)
The reducing power of DEM was established by FRAP assay
(Oyaizu, 1986) adapted to microscale using trolox as a stan-
dard. Brieﬂy, 40 lL M. nigra extract was mixed with 100 lL
sodium phosphate buffer (pH = 6.6) and 100 lL 1% potas-
sium ferricyanide. The mixture was incubated for 20 min at
50 C and then cooled. Next, 100 lL 10% trichloroacetic acid
was added. The mixture was then centrifuged at 3000g for
10 min, and 100 lL was taken from each of the upper phases.
This was mixed with 100 lL pure water and 20 lL 0.1% of fer-
ric chloride. The ﬁnal mixture was incubated for 5 min in the
dark and at room temperature. Absorbance was then mea-
sured at 700 nm. The results were calculated from a standard
trolox chart and were expressed as milligrams of trolox equiv-
alent per g sample.
2.3.3. HPLC analysis of phenolic compounds
Nine standards were used for HPLC analysis: ascorbic
acid, gallic acid, 3,4-dihydroxy benzoic acid, protocatechuic
acid, chlorogenic acid, caffeic acid, epigallocatechin gallate,
p-coumaric acid and rutin hydrate.
HPLC analysis of phenolic compounds was performed
using a reverse phase C18 column (150  4.6 mm i.d, 5 lm)
(Macherey-Nagel, Duren, Germany), on a gradient program
with a two solvent systems (A: 2% acetic acid in water and
B: 0.5% acetic acid in acetonitrile:water (1:1)) at a constant
solvent ﬂow rate of 0.8 mL/min on a HPLC system (Agilent
Inﬁnity 1200, CA, USA) (De Villiers et al., 2004). Injection
volume was 10 lL. Signals were detected at 240, 254, 260,
270, 275, 280, 300 and 324 nm by DAD. Column temperature
was maintained at room temperature, 25 C. Identiﬁcation of
compounds was performed by comparing retention times
and spectral data with those of pure standards. Calibration
curves of the standards were used for quantitation.
2.4. Cell culture
Human prostate adenocarcinoma (PC-3, ATCC-CRL-1435)
cancer and human normal foreskin ﬁbroblast cells (ATCC-
CRL-2522) were supplied by the America Type Culture Collec-
tion (Manassas, VA, USA). PC-3 and ﬁbroblast cells were cul-
tured in F-12K and EMEM medium, respectively,
supplemented with 2 mM L-Glutamine, 10% heat inactivated
FBS, 1% penicillin and streptomycin with a 5% CO2 supply
at 37 C.
2.4.1. Cytotoxicity assay
Cytotoxic effects of DEM and cisplatin on PC-3 and normal
ﬁbroblast cells were determined by MTT assay with 72 h treat-
ment (Mosmann, 1983). MTT is a type of yellow tetrazolium
salt and is converted to dark blue formazan crystals by
metabolically active cells (Russo et al., 2004). Brieﬂy, cells werePlease cite this article in press as: Turan, I. et al., Antiproliferative and apoptotic eﬀe
Journal (2016), http://dx.doi.org/10.1016/j.jsps.2016.06.002seeded into a ﬂat-bottomed 96-well cell culture plate at a den-
sity of 5  103 cells per well. After 24 h, the cells were treated
with several concentrations of DEM (0–1000 lg/mL) and cis-
platin (0–10 lg/mL) for 72 h. Next, 10 lL of MTT solution
was added to each well, and the composed crystals were then
dissolved in DMSO. Finally, absorbance was measured at
570 nm using a microplate reader (Versamax, Molecular
Devices, California, USA). Optical densities were used to
determine % cell viabilities using the formula (OD of treated
group/OD of control group)  100 in treated cells compared
to control cells with no compound exposure (Deepa et al.,
2012).
Log-concentrations versus % cell viabilities graphs were
plotted. IC50 values were determined using this logarithmic
graph. IC50 represents the concentration in ‘‘lg/mL” required
for 50% inhibition of cell growth compared to negative control
cells (Demir et al., 2016). Following the cytotoxicity experi-
ments, the cytotoxic IC50 and IC90 concentrations of DEM
and both IC50 (370 lg/mL) and IC90 (666 lg/mL) concentra-
tions obtained were used for ﬂow cytometry studies.
2.4.2. Cell cycle analysis
A total of 75  104 cells were cultured in T-25 ﬂasks for 24 h.
These were then treated with 370 and 666 lg/mL concentra-
tions of DEM for 72 h and harvested. Cell suspensions were
centrifuged for 5 min at 300g at room temperature. The super-
natants were then aspirated, and cell pellets were washed twice
with buffer solution. To the cell pellets was added 250 lL Solu-
tion A (trypsin buffer), and this was incubated at room tem-
perature for 10 min. At the end of that time, 200 lL Solution
B (trypsin inhibitor and RNase buffer) was added to the mix-
ture, which was again incubated for 10 min at room tempera-
ture. Finally, the tubes were placed on ice and 200 lL cold
Solution C (PI stain solution) was added. All procedures were
carried out according to the manufacturer’s recommendations
(BD Biosciences, Cat No: 340242, San Diego, CA, USA). Data
from 3  104 cells were collected and analyzed on a ﬂow
cytometer (FACSCalibur, Becton Dickinson, East Rutherford,
NJ, USA). The results were compared with the negative (no
treatment) control.
2.4.3. Annexin V analysis
A total of 75  104 cells were cultured in T-25 ﬂasks for 24 h.
These were then treated with 370 and 666 lg/mL concentra-
tions of DEM for 72 h and harvested. Cell suspensions were
centrifuged for 5 min at 300g at room temperature. Then,
the supernatants were aspirated, and cell pellets were washed
twice with cold PBS buffer. To the cell pellets was added
100 lL 1 Binding Buffer. Next, to the cell suspension were
added 5 lL of FITC Annexin V and 5 lL PI. The mixture
was then incubated for 15 min, in the dark at room tempera-
ture. All procedures were carried out according to the manu-
facturer’s recommendations (BD Pharmingen, Cat No:
556547, San Diego, CA, USA). Data from 104 cells were
collected and analyzed on a ﬂow cytometer (FACSCalibur,
Becton Dickinson, East Rutherford, NJ, USA). The results
were compared with the negative (no treatment) control.
2.4.4. Determination of mitochondrial membrane potential
Mitochondrial membrane potential was determined using a
JC-1 assay kit (BD Mitoscreen, Cat No: 551302, San Diego,ct of Morus nigra extract on human prostate cancer cells. Saudi Pharmaceutical
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rescence at a low level of mitochondrial membrane potential,
but the state of high mitochondrial membrane potential it
forms aggregates and emits red ﬂuorescence (Xuan et al.,
2014).
A total of 75  104 cells were cultured in T-25 ﬂasks for
24 h. These were then treated with 370 and 666 lg/mL concen-
trations of DEM for 72 h and harvested. Cell suspensions were
centrifuged for 5 min at 300g at room temperature. The super-
natant part was removed, and 500 lL JC-1 Working Solution
was added to the cell pellets and incubated for 15 min at 37 C.
At the end of that time the mixture was centrifuged at 400g for
5 min. The supernatants were then aspirated, and cell pellets
were washed twice with 1  Assay Buffer. All procedures were
carried out according to the manufacturer’s recommendations.
Data from 104 cells were collected and analyzed on a ﬂow
cytometer (FACSCalibur, Becton Dickinson, East Rutherford,
NJ, USA). The results were obtained from the ratio of red to
green ﬂuorescence and were expressed as relative mitochon-
drial membrane potential compared to negative control sam-
ples (cells with no test compound).
2.4.5. Determination of caspase activity
Effector caspase activities were determined using a Caspase-
Glo 3/7 luminescent assay kit according to the manufac-
turer’s recommendations (Promega, Cat No: G8090, Madison,
WI, USA). Cells were seeded in a 96-well white-walled cell cul-
ture plate at a density of 5  103 cells/well. After 24 h, the cells
were treated with several concentrations of DEM (250, 500,
and 1000 lg/mL) for 18 h. After treatment, the media were dis-
carded, and the cells were washed with PBS. Next, 100 lL of
Caspase-Glo 3/7 reagent was added to the wells, following
by mixing on a plate shaker at 400 rpm for 30 s. The plate
was incubated at room temperature for 30 min and the lumines-
cence of each sample was read on a plate-reading luminometer
(Molecular Devices SpectraMax Paradigm Multi-Mode,
Sunnyvale, CA, USA). Results were given as relative caspase
activity compared to negative control samples (cells with no test
compound).
2.5. Statistical analysis
All experiments were carried out in triplicate, and results were
expressed as mean ± standard deviation (mean ± S.D). Com-
patibility with normal distribution was determined using the
Kolmogorov–Smirnov test. One-way ANOVA was used to
compare differences among the groups. p< 0.05 was regarded
as signiﬁcant.
3. Results
TPC and FRAP values were 20.7 ± 0.3 mg gallic acid equiva-
lents and 48.8 ± 1.6 mg trolox equivalents per g sample,
respectively.
The chromatogram of phenolic standards is shown in
Fig. 1. The phenolic compounds in M. nigra are shown in
Table 1. The values were stated in lg/g sample. Ascorbic acid
and chlorogenic acid were the most abundant compounds in
M. nigra (Table 1). The small peak of ascorbic acid in Fig. 1
(at 280 nm) is due its maximum wavelength is 240 nm. 3,4-
dihydroxy benzoic acid and protocatechuic acid had the samePlease cite this article in press as: Turan, I. et al., Antiproliferative and apoptotic eﬀe
Journal (2016), http://dx.doi.org/10.1016/j.jsps.2016.06.002retention times and DAD spectra in our study. We therefore
determined the quantities of these separately based on their
calibration curves.
The PC-3 and ﬁbroblast cells were treated with various con-
centrations of DEM and cisplatin. Their effects on cell prolif-
eration were determined after 72 h based on cells’ ability to
metabolically reduce MTT to a formazan dye. The IC50 values
for DEM and cisplatin are presented in Table 2. DEM exhib-
ited moderate selective cytotoxicity against PC-3 cells com-
pared to foreskin ﬁbroblast cells.
The cell cycle analysis results are summarized in Fig. 2.
Both concentrations of DEM signiﬁcantly increased cell num-
bers at the G0/G1 phase (p< 0.01 and p< 0.01, respectively).
Both concentrations of DEM also signiﬁcantly reduced cell
numbers at the S phase (p< 0.01 and p< 0.05, respectively).
The Annexin V analysis results are summarized in Fig. 3.
Concentrations of 370 lg/mL of DEM increased the number
of early apoptotic and dead cells, but the differences were
not statistically signiﬁcant (p> 0.05). However, concentra-
tions of 666 lg/mL of DEM signiﬁcantly reduced the number
of viable cells and increased those of dead, necrotic/late apop-
totic and early apoptotic cells (p< 0.001).
Mitochondrial membrane potential analysis results are pre-
sented in Fig. 4. Both concentrations of DEM signiﬁcantly
reduced mitochondrial membrane potential in PC-3 cells
(p< 0.001). The percentage reductions in mitochondrial mem-
brane potential by DEM were 26.4% and 62.5% for concen-
trations of 370 and 666 lg/mL DEM, respectively.
Caspase 3 and caspase 7 are key mediators of apoptosis
because of their ability to cleave key cellular proteins. We mea-
sured the activity of caspase 3/7 using a luminometric kit for
18 h treatment. The percentage inductions of relative caspase
3/7 activity by DEM were 3%, 11% and 70% for concentra-
tions of 250, 500 and 1000 lg/mL DEM, respectively, although
the only signiﬁcant increase (p< 0.001) was determined in the
concentration of 1000 lg/mL DEM (Fig. 5).4. Discussion
Cancer is a heterogeneous disease that can involve a genetic
history due to multiple alterations of cell signaling pathways
(Luo et al., 2009). Traditional chemotherapy is often associ-
ated with adverse effects on healthy cells and gradual drug
resistance in cancer cells (Huang et al., 2011). Medicinal plants
have been investigated as a potential new source of cancer
therapy based on ability to produce apoptosis and/or growth
arrest in cancer cells without causing cytotoxic effect in healthy
cells (Shahneh et al., 2014).
Plants are excellent sources of food, chemicals and herbal
medicines. Many important drugs have been derived from
these (Khalid et al., 2011). M. nigra is one of the most
important species of the genus Morus, the fruits containing
substantial levels of phenolics, ﬂavonoids, and ascorbic acid
(Kostic et al., 2013). It has recently been reported to exhibit
biological properties, such as antidiabetic, antioxidative, anti-
inﬂammatory and antihyperlipidemic activities. These biologi-
cal activities are due to the polyphenol components, including
anthocyanins, present in some varieties (Kutlu et al., 2011;
Kamiloglu et al., 2013). Various studies have investigated
in vitro antiproliferative and proapoptotic characteristics of
different Morus species in the recent years (Fathy et al.,ct of Morus nigra extract on human prostate cancer cells. Saudi Pharmaceutical
Table 1 Phenolic composition of the DMSO extract ofMorus
nigra L.
Phenolic compound assignment Retention
time (min)
Amount
(lg/g sample)
Ascorbic acid 3.99 1995.7 ± 59.9
Gallic acid 6.80 7.5 ± 0.3
3,4-dihydroxy benzoic acid 10.65 88.6 ± 4.43
Protocatechuic acid 10.65 114 ± 5.13
Chlorogenic acid 18.95 309.6 ± 20.1
Caﬀeic acid 20.56 ND
Epigallocatechin gallate 22.28 ND
p-coumaric acid 26.23 134.7 ± 6.1
Rutinhydrate 27.88 71.6 ± 2.5
Results are expressed as mean ± SD of three determinations. ND,
not detected.
Table 2 Cytotoxic activity (IC50, lg/mL) of DEM and
cisplatin (n= 3).
Test compound PC-3 cells Fibroblast cells
DEM 370.1 ± 5.8 424.9 ± 7.3
Cisplatin 0.608 ± 0.05 5.29 ± 0.24
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Figure 2 Cell cycle analysis of the effect of DEM extract on PC-
3 cells after 72 h (n= 3). aRepresents signiﬁcant results (p< 0.05)
compared with untreated PC-3 cells.
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Figure 3 Annexin V-FITC analysis of DEM-treated PC-3 cells
(n= 3). aRepresents signiﬁcant results (p< 0.05) compared with
untreated PC-3 cells.
Figure 1 Chromatogram of standard phenolic acids (at 280 nm) in the optimum HPLC conditions in the experimental protocol. Peaks:
ascorbic acid (1), gallic acid (2), 3,4-dihydroxy benzoic acid (3), protocatechuic acid (4), chlorogenic acid (5), caffeic acid (6),
epigallocatechin gallate (7), p-Coumaric acid (8), rutin hydrate (9).
Antiproliferative and apoptotic effect of Morus nigra extract 52013; Eo et al., 2014), but studies involving the in vitro cyto-
toxic effect of M. nigra extract are very limited (Qadir et al.,
2014). No previous studies have investigated the cytotoxic
effect of M. nigra extract on prostate cancer. Sforcin and
Bankova reported that in vitro methods are useful for prelim-
inary investigation of the possible beneﬁcial biological effects
of a natural product. If positive results are obtained from
in vitro studies, then in vivo or clinical trials are recommended
(Sforcin and Bankova, 2011). The PC-3 cell line is an androgen
receptor negative prostate cancer cell line with high metastatic
potential frequently in cancer research for in vitro prostate can-
cer models (Shahneh et al., 2014; Huo et al., 2015). We there-
fore planned this study on the prostate cancer cell line (PC-3)
under in vitro conditions.Please cite this article in press as: Turan, I. et al., Antiproliferative and apoptotic eﬀect of Morus nigra extract on human prostate cancer cells. Saudi Pharmaceutical
Journal (2016), http://dx.doi.org/10.1016/j.jsps.2016.06.002
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Figure 4 Effect of DEM on the integrity of the mitochondrial
membrane of PC-3 cells after 72 h (n= 3). aRepresents signiﬁcant
results (p< 0.05) compared with untreated PC-3 cells.
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Figure 5 Detection of caspase-3/7 activity in PC-3 cells treated
with DEM for 18 h (n= 3). aRepresents signiﬁcant results
(p< 0.05) compared with untreated PC-3 cells.
6 I. Turan et al.Many methods are available for extraction of active com-
ponents from plant materials. Maceration is one such tech-
nique. In this method, many solvents, such as water, ethanol,
methanol, ethyl acetate, dimethyl sulfoxide, hexane or acetone,
are used to extract the components from plant materials
directly without compromising the structure (Dai and
Mumper, 2010). The DMSO extract of M. nigra was prepared
using the maceration technique in this study.
Various in vitro assays can be used to determine antioxidant
activity of herbal extracts, and the use of at least two different
methods is recommended (Nuutila et al., 2003). The TPC and
FRAP methods were employed for the determination of
antioxidant activity of DEM in this study. TPC and FRAP
values of M. nigra extract were 20.7 ± 0.3 mg gallic acid
equivalents and 48.8 ± 1.6 mg trolox equivalents per g sample,
respectively. The TPC values of various extracts of M. nigra
fruit from different regions range between 1.69 and 22.37 mg
gallic acid equivalents/g sample (Kostic et al., 2013), while
the FRAP value of 75% aqueous-methanol extract ofM. nigra
fruit from Turkey has been reported at 3.8 mg trolox equiva-
lents/g sample (Kamiloglu et al., 2013). Our results were
broadly similar to those of other studies. Any differences
may have been due to the type of extraction method and sol-
vent, environmental factors, soil, geographic region, harvestPlease cite this article in press as: Turan, I. et al., Antiproliferative and apoptotic eﬀe
Journal (2016), http://dx.doi.org/10.1016/j.jsps.2016.06.002season, post-harvesting conditions and the maturity level of
the fruits.
Several reports have described the use of HPLC with a
diode array detector (DAD) for the characterization and quan-
tiﬁcation of phenolic composition (Boligon and Athayde,
2014). We used the HPLC-DAD spectra system for phyto-
chemical analysis. Seven phenolic compounds (ascorbic acid,
gallic acid, 3,4-dihydroxy benzoic acid, protocatechuic acid,
chlorogenic acid, p-coumaric acid and rutin hydrate) were
determined in the DEM. These results agree with previous
research showing that the genus Morus is rich in polyphenolic
compounds such as cyanidin-3-glucoside, kaempferol-3-O-
rutinoside, rutin, quercetin, catechin, quercetin-3-O-
glucoside, quercetin-3-O-rutinoside, taxifolin, chlorogenic
acid, p-coumaric acid, vanillic acid, gallic acid, ferulic acid, caf-
feic acid, and syringic acid (Hassimotto et al., 2007; Gundogdu
et al., 2011; Kostic et al., 2013).
An effective and acceptable chemopreventive or anticancer
agent has to meet various criteria, including having no harmful
effects on normal cells (Galati and O’Brien, 2004). We there-
fore performed cytotoxicity experiments in PC-3 cells coupled
with human normal foreskin ﬁbroblast cells. DEM exhibited
reasonable selective toxicity against PC-3 cells compared to
normal ﬁbroblast cells via MTT assay, a nonradioactive,
quick, and affordable method widely used in cytotoxicity stud-
ies (Russo et al., 2004). Qadir et al. demonstrated thatM. nigra
leaf extract exhibited cytotoxic effect on a human cervical can-
cer (HeLa) cell line (Qadir et al., 2014). Shi et al. isolate numer-
ous ﬂavonoids with isoprenoid groups from Morus mongolica
and demonstrate selective cytotoxic activity in two human oral
cancer cell lines (HSC-2 and HSG) against normal human gin-
gival ﬁbroblasts (Shi et al., 2001). In another study, Fathy
et al. reported that M. alba extract exhibits cytotoxic effect
on the hepatocellular cell line (Fathy et al., 2013), while Kofu-
jita et al. demonstrated that prenylated ﬂavanone separated
fromM. alba root shows cytotoxic effect against rat hepatoma
cells (Kofujita et al., 2004). Additionally, Dat et al. isolated 11
ﬂavonoids from the leaves of the white mulberry and evaluated
their cytotoxic effect on three human cancer cell lines (HeLa,
MCF-7 and Hep3B). Morusin was identiﬁed as the most
potent cytotoxic compound against HeLa cells (Dat et al.,
2010).
Many recent studies have concluded that cancer can be
regarded as a disease of the cell cycle due to ineffective cell
cycle checkpoint control. Cell cycle arrest of cancer cells is
therefore regarded as one of the target mechanisms in cancer
treatment (Diaz-Moralli et al., 2013). In this study, an IC90
concentration of DEM blocked the cell cycle of PC-3 cells at
the G0/G1 phase, and both concentrations of DEM signiﬁ-
cantly reduced cell numbers at the S phase. This ﬁnding is sig-
niﬁcant because the cells did not achieve the next S phase
involving intense protein and DNA synthesis. Both extracts
of differentMorus species and their constituents, such as lectin,
gallic acid, ascorbic acid, and chlorogenic acid, can induce cell
cycle arrest at different stages of the cell cycle, depending on
the type of cancer cell by increasing the levels of cell cycle pro-
gression inhibitors or reducing levels of cyclins and CDKs
(Thomas et al., 2005; Ou et al., 2010; Deepa et al., 2012; Liu
et al., 2013; Eo et al., 2014).
Attenuate or extinct apoptosis capacity is reported in many
cancer cells. Increasing apoptotic levels by various agents are
therefore another target mechanisms in cancer cells (Reed,ct of Morus nigra extract on human prostate cancer cells. Saudi Pharmaceutical
Antiproliferative and apoptotic effect of Morus nigra extract 71999). Caspases (cysteine-dependent aspartate-speciﬁc pro-
teases) are activated during the early stages of apoptosis. These
are synthesized as inactive zymogens but, once activated, can
initiate a proteolytic cascade, resulting in the cleavage of key
cellular components required for normal cellular function. Ele-
vated caspase 3, 6 and/or 7 activity is regarded as an apoptosis
marker. When cells are undergoing apoptosis, phos-
phatidylserine (PS), which makes up one part of the cell mem-
brane, will translocate toward the extracellular side of the
membrane. Annexin V, a 35–36 kDa phospholipid-binding
protein, has a high afﬁnity for PS. The translocation of PS
to the outside or exposed side of the membrane is an early
event in the apoptotic process. Annexin V staining is therefore
regarded as a marker of early stage apoptosis (Deepa et al.,
2012). Our results show that DEM potentially exhibited
proapoptotic features in PC-3 cells both inducing caspase
activity and reducing mitochondrial membrane potential.
Huang et al. demonstrated that anthocyanins from mulberry
exhibit activity against gastric cancer through the mechanism
of induction of apoptosis via the activation of the p38/jun/
Fas/FasL and p38/p53/Bax pathways that initiate cell death
(Huang et al., 2011). Yang et al. showed that mulberry leaf
polyphenol extract (especially rich in quercetin and rutin)
induces apoptosis in p53-negative hepatocellular carcinoma
cells via the p53-independent pathway (Yang et al., 2012).
Kikuchi et al. showed that albanol A (isolated from the root
bark extract of M. alba) exhibited cytotoxic activity on HL-
60 leukemia cell line via inhibitory activity on topoisomerase
II and inducing the caspase-dependent apoptosis pathway
(Kikuchi et al., 2010). Recently, it has been reported that puri-
ﬁed lectin from mulberry leaves induces apoptosis and cell
cycle arrest in human breast (MCF-7) and colon (HCT-15)
cancer cells in a caspase-dependent manner (Deepa et al.,
2012).
It has been strongly suggested that the anticancer and
proapoptotic properties of polyphenolic compounds derive
from their pro-oxidant activities, rather than from antioxi-
dant activity (Hadi et al., 2000). Although polyphenolic com-
pounds are able to exhibit pro-oxidant effects under various
conditions, they do not generally produce free radicals
directly. Their pro-oxidant effect is widely associated with
the redox status of the cell, and the basal redox levels of can-
cer cells are high compared to those of normal cells due to
their greater levels of free heavy metal ions and increased
metabolic rate (Lee et al., 2013). Jeong et al. reported that
mulberry fruit extracts have cytotoxic effect on human
glioma cells through ROS-dependent mitochondrial pathway
and induction of apoptosis (Jeong et al., 2010). We therefore
speculate that the apoptotic and antiproliferative effects of
DEM in PC-3 cells may derive from its ROS formation
capacity.5. Conclusion
This study was the ﬁrst to investigate the effect of pro-
apoptotic and antiproliferative properties of M. nigra extract
on prostate cancer cells. Further studies are required for the
isolation and identiﬁcation of individual phenolic compounds
in the extracts. Also, the phytochemical studies together with
in vivo biological activity investigations are essential for com-
plete understanding of the medicinal applications.Please cite this article in press as: Turan, I. et al., Antiproliferative and apoptotic eﬀe
Journal (2016), http://dx.doi.org/10.1016/j.jsps.2016.06.002Acknowledgment
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